Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsNick van Es, Harry R. Büller, Michiel Coppens et al.|Blood|2014Cited by 840
Factor XI Antisense Oligonucleotide for Prevention of Venous ThrombosisHarry R. Büller, Jeffrey I. Weitz, Claudette Bethune et al.|New England Journal of Medicine|2014Cited by 621
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsAlexander T Cohen, Victor F. Tapson, Theodore E. Spiro et al.|New England Journal of Medicine|2013Cited by 603
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Marc Rodger, Paul A. Kyrle et al.|BMJ|2019Cited by 312
The Absolute Risk of Venous Thrombosis after Air Travel: A Cohort Study of 8,755 Employees of International OrganisationsSaskia Kuipers, Frits R. Rosendaal, Suzanne C. Cannegieter et al.|PLoS Medicine|2007Cited by 143